Ann: FOD reaffirms $40M FY20 guidance, page-157

Correct. ASX say you need shareholder approval for the extension, so instead they don't grant the extension but just take no action to enforce the debt. This is becoming more and more disastrous by the week.

Financials still not due til end of August. Still no news on all the other products they were meant to be launching. Their plant is in Victoria, and no update on whether their operations are being affected by the second wave.

I held this last time it traded at $0.04 and at this rate it will be back there in no time.

The upside is the juice business (OBL at least) appears to be very strong, and their Mill Park facility gives plenty of potential upside for new products and ability to meet changing demands (eg, bottling sanitiser, which would no doubt have been extremely lucrative if it wasn't mixed in with Careline). On that note, what happened to our "Sanicare" brand that was apparently launching? And the disinfectant?

Not one for blaming someone for things outside of their control, but the buck surely has to stop with Norman now. China plans have failed miserably. PR at all time low. Market communications not fit for an ASX listed company.